Oxidative stress in prostate cancer patients: A systematic review of case control studies

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Secondary Globocan 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. Grönberg, 2003, Prostate cancer epidemiology, Lancet, 361, 859, 10.1016/S0140-6736(03)12713-4 Loblaw, 2007, Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2007 Update of an American Society of Clinical Oncology Practice Guideline, J Clin Oncol, 25, 1596, 10.1200/JCO.2006.10.1949 Lund, 2014, Prostate cancer: a review of active surveillance, Res Rep Urol, 6, 107 Kalyanaraman, 2013, Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms, Redox Biol, 1, 244, 10.1016/j.redox.2013.01.014 Khandrika, 2009, Oxidative stress in prostate cancer, Cancer Lett, 282, 125, 10.1016/j.canlet.2008.12.011 Chen, 2001, Oxidative DNA damage in prostate cancer patients consuming tomato sauce-based entrees as a whole-food intervention, J Natl Cancer Inst, 93, 1872, 10.1093/jnci/93.24.1872 Wang, 2015, Effect of carotene and lycopene on the risk of prostate cancer: a systematic review and dose-response meta-analysis of observational studies, PLoS One, 10, e0137427, 10.1371/journal.pone.0137427 Reuter, 2010, Oxidative stress, inflammation, and cancer: how are they linked?, Free Radical Bio Med, 49, 1603, 10.1016/j.freeradbiomed.2010.09.006 Minelli, 2009, Oxidative stress-related aging: a role for prostate cancer?, Biochim Biophys Acta, 1795, 83 Ripple, 1997, Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells, J Natl Cancer Inst, 89, 40, 10.1093/jnci/89.1.40 Mehraein-Ghomi, 2008, JunD mediates androgen-induced oxidative stress in androgen dependent LNCaP human prostate cancer cells, Prostate, 68, 924, 10.1002/pros.20737 Huggins, 1972, Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate, CA Cancer J Clin, 22, 232, 10.3322/canjclin.22.4.232 Miyake, 2004, Protection of androgen-dependent human prostate cancer cells from oxidative stress-induced DNA damage by overexpression of clusterin and its modulation by androgen, Prostate, 61, 318, 10.1002/pros.20087 1994, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers, N Engl J Med, 330, 1029, 10.1056/NEJM199404143301501 Greenlee, 2009, Use of antioxidant supplements during breast cancer treatment: a comprehensive review, Breast Cancer Res Treat, 115, 437, 10.1007/s10549-008-0193-0 Nechuta, 2011, Vitamin supplement use during breast cancer treatment and survival: a prospective cohort study, Cancer Epidemiol Biomarkers Prev, 20, 262, 10.1158/1055-9965.EPI-10-1072 Albanes, 2000, Effects of supplemental alpha-tocopherol and beta-carotene on colorectal cancer: results from a controlled trial (Finland), Cancer Causes Control, 11, 197, 10.1023/A:1008936214087 Wang, 1994, Effects of vitamin/mineral supplementation on the prevalence of histological dysplasia and early cancer of the esophagus and stomach: results from the General Population Trial in Linxian, China, Cancer Epidemiol Biomarkers Prev, 3, 161 Bairati, 2005, Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients, J Clin Oncol, 23, 5805, 10.1200/JCO.2005.05.514 Kennedy, 2004, Low antioxidant vitamin intakes are associated with increases in adverse effects of chemotherapy in children with acute lymphoblastic leukemia, Am J Clin Nutr, 79, 1029, 10.1093/ajcn/79.6.1029 Lotan, 2012, Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT, J Urol, 187, 2005 Lippman, 2009, Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the selenium and vitamin e cancer prevention trial (select), JAMA, 301, 39, 10.1001/jama.2008.864 Gaziano, 2009, Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial, JAMA, 301, 52, 10.1001/jama.2008.862 Bouayed, 2010, Exogenous antioxidants—Double-edged swords in cellular redox state: health beneficial effects at physiologic doses versus deleterious effects at high doses, Oxid Med Cell Longev, 3, 228, 10.4161/oxim.3.4.12858 2011 Wells, 2013 Stang, 2010, Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses, Eur J Epidemiol, 25, 603, 10.1007/s10654-010-9491-z Oremus, 2012, Inter-rater and test–retest reliability of quality assessments by novice student raters using the Jadad and Newcastle–Ottawa Scales, BMJ Open, 2, 10.1136/bmjopen-2012-001368 Hartling, 2013, Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers, J Clin Epidemiol, 66, 982, 10.1016/j.jclinepi.2013.03.003 Camphausen, 2004, Isoprostane levels in the urine of patients with prostate cancer receiving radiotherapy are not elevated, Int J Radiat Oncol, 58, 1536, 10.1016/j.ijrobp.2003.09.011 Hoque, 2010, Serum oxidized protein and prostate cancer risk within the prostate cancer prevention trial, Cancer Prev Res, 3, 478, 10.1158/1940-6207.CAPR-09-0201 Klotz, 1998, Selective expression of inducible nitric oxide synthase in human prostate carcinoma, Cancer, 82, 1897, 10.1002/(SICI)1097-0142(19980515)82:10<1897::AID-CNCR12>3.0.CO;2-O Baltaci, 2001, Inducible nitric oxide synthase expression in benign prostatic hyperplasia, low- and high-grade prostatic intraepithelial neoplasia and prostatic carcinoma, BJU Int, 88, 100, 10.1046/j.1464-410x.2001.02231.x Iynem, 2004, The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems, Int Urol Nephrol, 36, 57, 10.1023/B:UROL.0000032676.31470.b2 Yilmaz, 2004, Antioxidant system activation in prostate cancer, Biol Trace Elem Res, 98, 13, 10.1385/BTER:98:1:13 Miyake, 2004, Oxidative DNA damage in patietns with prostate cancer and its response to treatment, J Urol, 171, 1533 Srivastava, 2005, Free radical injury and antioxidant status in patients with benign prostate hyperplasia and prostate cancer, Indian J Clin Biochem, 20, 162, 10.1007/BF02867419 Almushatat, 2006, Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer, Int J Cancer, 118, 1051, 10.1002/ijc.21451 Aydin, 2006, Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia, Clin Biochem, 39, 176, 10.1016/j.clinbiochem.2005.11.018 Ozmen, 2006, Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer, Clin Chem Lab Med, 44, 175, 10.1515/CCLM.2006.032 Surapaneni, 2006, Lipid peroxidation and antioxidant status in patients with carcinoma of prostate, Indian J Physiol Pharmacol, 50, 350 Yossepowitch, 2007, Advanced but not localized prostate cancer is associated with increased oxidative stress, J Urol, 178, 1238 Kotrikadze, 2008, Activity and content of antioxidant enzymes in prostate tumors, Exo Oncol, 30, 244 Akinloye, 2009, Changes in antioxidant status and lipid peroxidation in Nigerian patients with prostate carcinoma, Pol Arch Med Wewn, 119, 526 Arsova-Sarafinovska, 2009, Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer, Clinc Biochem, 42, 1228, 10.1016/j.clinbiochem.2009.05.009 Battisti, 2011, Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis, Biomed Pharmacother, 65, 516, 10.1016/j.biopha.2011.06.003 Barocas, 2011, Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer, J Urol, 185, 2102 Wozniak, 2012, Oxidative stress markers in prostate cancer patients after HDR brachytherapy combined with external beam radiation, Oxid Med Cell Longev, 2012, 789870, 10.1155/2012/789870 Brys, 2013, Relationship of urinary isoprostanes to prostate cancer occurrence, Mol Cell Biochem, 372, 149, 10.1007/s11010-012-1455-z Pande, 2013, Simultaneous progression of oxidative stress, angiogenesis, and cell proliferation in prostate carcinoma, Urol Oncol, 31, 1561, 10.1016/j.urolonc.2012.04.012 Kosova, 2014, Possible relations between oxidative damage and apoptosis in benign prostate hyperplasia and prostate cancer patients, Tumor Biol, 35, 4295, 10.1007/s13277-013-1560-y Yang, 2015, Impact of oxidative stress biomarkers and carboxymethyllysine (an advanced glycation end product) on prostate cancer: a prospective study, Clin Genitourin Cancer, 13, e347, 10.1016/j.clgc.2015.04.004 Rajneesh, 2008, Lipid peroxidation and antioxidant status in patients with breast cancer, Singapore Med J, 49, 640 Sener, 2007, Lipid peroxidation and total antioxidant status in patients with breast cancer, Cell Biochem Funct, 25, 377, 10.1002/cbf.1308 YİLmaz, 2006, Lipid peroxidation in patients with brain tumor, Int J Neurosci, 116, 937, 10.1080/00207450600553141 Jiao, 2011, Advanced glycation end-products, soluble receptor for advanced glycation end-products and risk of colorectal cancer, Cancer Epidemiol Biomarkers Prev, 20, 1430, 10.1158/1055-9965.EPI-11-0066 Kaynar, 2005, Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu–Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer, Cancer Lett, 227, 133, 10.1016/j.canlet.2004.12.005 Suman, 2012, Activities of some antioxidant enzymes and lipid peroxidation in liver cancer patients, Int J Curr Res Rev, 4, 59 Dahiya, 2012, Nitric oxide and antioxidant status in head and neck carcinoma before and after radiotherapy, Ann Clin Lab Sci, 42, 94 Rasool, 2014, Comparative studies of salivary and blood sialic acid, lipid peroxidation and antioxidative status in oral squamous cell carcinoma (OSCC), Pak J Med Sci, 30, 466 Pratt, 2011, Free radical oxidation of polyunsaturated lipids: new mechanistic insights and the development of peroxyl radical clocks, Acc Chem Res, 44, 458, 10.1021/ar200024c Moselhy, 2013, A specific, accurate, and sensitive measure of total plasma malondialdehyde by HPLC, J Lipid Res, 54, 852, 10.1194/jlr.D032698 Karimi Galougahi, 2015, Redox biomarkers in cardiovascular medicine, Eur Heart J, 36, 1576, 10.1093/eurheartj/ehv126 Lockett, 2006, DNA damage levels in prostate cancer cases and controls, Carcinogenesis, 27, 1187, 10.1093/carcin/bgi288 Malins, 2001, Age-related radical-induced DNA damage is linked to prostate cancer, Cancer Res, 61, 6025 Valavanidis, 2009, 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis, J Environ Sci Health C Environ Carcinog Exotoxicol Rev, 27, 120, 10.1080/10590500902885684 Valko, 2004, Role of oxygen radicals in DNA damage and cancer incidence, Mol Cell Biochem, 266, 37, 10.1023/B:MCBI.0000049134.69131.89 Saydam, 1997, Determination of glutathione, glutathione reductase, glutathione peroxidase and glutathione S-transferase levels in human lung cancer tissues, Cancer Lett, 119, 13, 10.1016/S0304-3835(97)00245-0 Backos, 2012, The role of glutathione in brain tumor drug resistance, Biomed Pharmacoher, 83, 1005 Townsend, 2003, The role of glutathione-S-transferase in anti-cancer drug resistance, Oncogene, 22, 7369, 10.1038/sj.onc.1206940